WATERTOWN, Mass., November 5, 2024 – Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of circular RNA medicines and unprecedented lipid nanoparticle (LNP) delivery solutions for oncology and autoimmune diseases, today announced an upcoming poster presentation at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego from December 7-10, 2024. The presentation will outline data supporting the exploration of its in vivo CAR therapy appr

**Multiple Early Partial Responses Alongside Encouraging Safety and Pharmacokinetic Data** DETROIT, Dec. 3, 2024 /PRNewswire/ -- SciTech Development, a clinical-stage pharmaceutical company focused on advancements in cancer treatment, is excited to share promising updates from its clinical trial of ST-001 nanoFenretinide (ST-001). Preliminary Trial Findings Preliminary data from the accelerated Phase 1a trial in patients with Cutaneous T-cell Lymphoma indicates favorable clinical improvements to

-Drives Continuous Innovation in Specialized Diagnostics to Power Patient Care- BEDFORD, Mass., Dec. 3, 2024 /PRNewswire/ -- Werfen today announced the opening of a new building, expanding its capabilities for innovation in Specialized Diagnostics, at its Hemostasis and Acute Care Diagnostics Technology Center, in Bedford, MA, USA. Werfen's Chairman, Marc Rubiralta, along with other senior leaders from Werfen, will host a ribbon-cutting ceremony at the Bedford campus. The new building adds 105,0

SAN FRANCISCO, Dec. 3, 2024 /PRNewswire/ -- InsightRX – the leader in Bayesian model-informed precision dosing (MIPD) software – today announced it will attend the ASHP 2024 Midyear Clinical Meeting & Exhibition as both an exhibitor and presenter. The meeting is scheduled for Dec. 8-12 at the Ernest N. Morial Convention Center in New Orleans. ASHP 2024 is organized by the American Society of Health-System Pharmacists and will include vendor exhibits, educational sessions, poster presentations, a

CHILLICOTHE, Ohio, Dec. 3, 2024 /PRNewswire/ -- As a patient with chronic obstructive pulmonary disease, or COPD, Kim Riffle of Jackson, Ohio, is no stranger to breathing difficulties. But when doctors in the Adena Regional Medical Center emergency department in Chillicothe found a hole in her right lung, Kim put her trust in thoracic surgeon Kevin Radecki, MD, at the Adena Heart and Vascular Institute, for the care and treatment she needed. "Dr. Radecki saved my life," she said. Kim was being t

▎Armstrong 2024年12月2日，Metsera在Clinicaltrials.gov网站上注册了MET-097的美国减重2b期临床试验。 MET-097为一款超长效GLP-1受体激动剂，采用HALP TM脂化修饰技术，人体半衰期约380小时（16天），为司美格鲁肽等GLP-1类产品的2-3倍，未来有望实现每月一针。此前公布的一期临床数据显示，单次给药从0.16mg爬坡至1.6mg，多次给药从0.2mg爬坡至1.2mg，五次给药且没有采取滴定过程。1.2mg剂量组治疗5周后减重7.5%，最后一次停药后4周减重幅度扩大到8.1%，提示药效保持时间与超长半衰期相符合。 此次启动的减重二期临床试验，计划入组225例肥胖患者，连续16周给药，每周给药，不需要进行剂量滴定，16周后继续随访11周（5倍半衰期）。 Metsera于今年4月走出隐匿模式，当时已完成2.9亿美元A轮融资，最近又宣布完成2.15亿美元B轮融资。管理团队方面，首席执行官是Clive Meanwell，他曾是The Medicines Company 的首席执行官。 Metsera的核心管线除MET-097之外，还

Reviews Clinical Trends and Data from HeadSMART II and NIH-funded Geriatric Clinical Trials of the BRAINBox Tests in presentations and publications RICHMOND, Va., Dec. 3, 2024 /PRNewswire/ -- BRAINBox Solutions today provided an update on the development of its BRAINBox TBI concussion diagnostic/prognostic tests for adult, senior, and pediatric patients. The company also highlighted trends and data from the HeadSMART II pivotal trial in adult patients and the National Institutes of Health-funde

TORRANCE, Calif., Dec. 3, 2024 /PRNewswire/ -- In the spirit of Giving Tuesday, a global movement that celebrates generosity and the power of giving back, Sunrider International, a global leader in health and wellness, proudly announces the continuation of its philanthropic partnership with Engage Now Africa (ENA), a nonprofit organization committed to empowering vulnerable communities across Africa. Building on four years of impactful collaboration, Sunrider's most recent donation in 2024 has b

JERSEY CITY, N.J., Dec. 3, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced 10 presentations covering advances in amyotrophic lateral sclerosis (ALS) research at the Motor Neurone Disease Association (MNDA) 35th International Symposium on ALS/MND, being held in Montreal, Canada, from December 6-8. "We are honored to participate in this year's MNDA symposium, where we will share insights from our preclinical, clinical and real-world studies on RADICAVA® (edaravo

Senior Leader Additions Deepen Excellence in Strategy and CreativeNEW YORK, Dec. 3, 2024 /PRNewswire/ -- Imre welcomes two new leaders reinforcing its Strategy and Creative functions as it continues to focus on deepening its healthcare agency-of-record engagements. Haifa Barbari joins in the new role of Executive Vice President of Strategy and Customer Experience, along with Senior Vice President, Group Creative Director of Copy, Joe Macera. Continue Reading Imre Welcomes Haifa Barbari and Joe M